Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
161.8 USD | +3.33% | +8.71% | -10.46% |
04-23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
04-23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.46% | 16.36B | |
-1.90% | 104B | |
+6.84% | 97.47B | |
+5.71% | 22.25B | |
-12.74% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
+6.68% | 14.39B | |
+35.58% | 12.37B | |
+306.58% | 8.43B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Ladenburg Thalmann Downgrades BeiGene to Neutral from Buy